Header cover image

German (DAX) Life Sciences Industry Analysis

UpdatedAug 31, 2025
DataAggregated Company Financials
Companies6
  • 7D-0.7%
  • 3M-7.9%
  • 1Y-28.7%
  • YTD-12.5%

Over the last 7 days, the Life Sciences industry has remained flat, although notably SCHOTT Pharma KGaA declined by 4.2%. As for the longer term, the industry has declined 29% in the last year. Earnings are forecast to grow by 28% annually.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 31 Aug 2025€18.5b€7.4b€157.8m23.5x117.1x2.5x
Tue, 29 Jul 2025€18.9b€7.4b€108.0m26x175x2.5x
Thu, 26 Jun 2025€20.5b€7.3b€114.9m28.8x178.3x2.8x
Sat, 24 May 2025€21.3b€7.3b€114.9m28.6x185.3x2.9x
Mon, 21 Apr 2025€19.6b€7.3b€112.4m25.9x174.2x2.7x
Wed, 19 Mar 2025€22.8b€7.1b€156.5m28.2x145.7x3.2x
Fri, 14 Feb 2025€23.6b€7.1b€169.8m24.3x138.8x3.3x
Sun, 12 Jan 2025€22.3b€7.1b€169.8m25.7x131.5x3.2x
Tue, 10 Dec 2024€21.7b€7.1b€170.5m26.5x127.2x3.1x
Thu, 07 Nov 2024€22.6b€7.1b€171.2m29.2x132.2x3.2x
Sat, 05 Oct 2024€23.0b€7.1b€177.5m30x129.7x3.2x
Mon, 02 Sep 2024€25.6b€7.1b€172.8m36x148.1x3.6x
Wed, 31 Jul 2024€25.4b€7.0b€237.1m36.4x107.2x3.6x
Fri, 28 Jun 2024€23.0b€7.0b€333.3m29.9x68.9x3.3x
Sun, 26 May 2024€25.5b€7.0b€333.3m31.5x76.6x3.7x
Tue, 23 Apr 2024€28.1b€7.0b€329.0m35.4x85.4x4x
Thu, 21 Mar 2024€34.6b€7.1b€384.5m39.2x89.9x4.9x
Sat, 17 Feb 2024€32.2b€7.3b€516.3m36.9x62.4x4.4x
Mon, 15 Jan 2024€30.7b€7.3b€507.1m35.5x60.5x4.2x
Wed, 13 Dec 2023€30.4b€7.3b€507.1m32.5x59.9x4.2x
Fri, 10 Nov 2023€26.9b€7.3b€498.8m31x53.9x3.7x
Sun, 08 Oct 2023€26.1b€6.6b€498.8m38.1x52.4x3.9x
Tue, 05 Sep 2023€31.0b€6.6b€498.1m45.4x62.2x4.7x
Thu, 03 Aug 2023€30.0b€6.6b€425.8m42.1x70.5x4.6x
Sat, 01 Jul 2023€26.9b€6.7b€487.3m37.5x55.2x4x
Mon, 29 May 2023€27.1b€6.7b€487.3m37.3x55.6x4x
Wed, 26 Apr 2023€27.6b€6.7b€483.0m37.6x57.1x4.1x
Fri, 24 Mar 2023€30.1b€6.7b€594.3m34.6x50.7x4.5x
Sun, 19 Feb 2023€32.2b€6.5b€447.4m40.3x71.9x5x
Tue, 17 Jan 2023€31.6b€6.5b€447.4m38.9x70.6x4.9x
Thu, 15 Dec 2022€28.8b€6.5b€447.4m34.6x64.5x4.5x
Sat, 12 Nov 2022€31.5b€6.5b€447.4m38.3x70.4x4.9x
Mon, 10 Oct 2022€28.6b€6.2b€573.0m53.3x49.9x4.6x
Wed, 07 Sep 2022€5.5b€2.3b€84.0m1204.2x65x2.4x
Price to Earnings Ratio

65x


Total Market Cap: €5.5bTotal Earnings: €84.0mTotal Revenue: €2.3bTotal Market Cap vs Earnings and Revenue0%0%0%
German Life Sciences Industry Price to Earnings3Y Average 95x202320242025
Current Industry PE
  • Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 117x which is higher than its 3-year average PE of 95.0x.
  • The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 23% per year over the last three years.
  • Revenues for these companies have grown 47% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market-1.56%
Healthcare-1.77%
Life Sciences-0.75%
Clinical Research and Equipment-0.75%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available